CN105521026A - Injection for treating epidemic cerebrospinal meningitis - Google Patents
Injection for treating epidemic cerebrospinal meningitis Download PDFInfo
- Publication number
- CN105521026A CN105521026A CN201610068053.6A CN201610068053A CN105521026A CN 105521026 A CN105521026 A CN 105521026A CN 201610068053 A CN201610068053 A CN 201610068053A CN 105521026 A CN105521026 A CN 105521026A
- Authority
- CN
- China
- Prior art keywords
- water
- injection
- medical material
- preparation
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002347 injection Methods 0.000 title claims abstract description 50
- 239000007924 injection Substances 0.000 title claims abstract description 50
- 201000009906 Meningitis Diseases 0.000 title claims abstract description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 238000011282 treatment Methods 0.000 claims description 36
- 239000012567 medical material Substances 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 27
- 239000003814 drug Substances 0.000 claims description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 21
- 241000466346 Neoalsomitra integrifoliola Species 0.000 claims description 19
- 239000010231 banlangen Substances 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 14
- 238000005325 percolation Methods 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 7
- 238000005202 decontamination Methods 0.000 claims description 7
- 230000003588 decontaminative effect Effects 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000004321 preservation Methods 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 238000001256 steam distillation Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 15
- 239000000463 material Substances 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 abstract description 4
- 241001226187 Cyrtomium fortunei Species 0.000 abstract 1
- 244000214240 Galinsoga parviflora Species 0.000 abstract 1
- 235000018914 Galinsoga parviflora Nutrition 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 241000229150 Neoalsomitra Species 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 9
- 206010040047 Sepsis Diseases 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 208000013223 septicemia Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 4
- 206010052369 Encephalitis lethargica Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 201000002498 viral encephalitis Diseases 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 210000002418 meninge Anatomy 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000003773 Meningism Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 208000034579 Acute haemorrhagic conjunctivitis Diseases 0.000 description 1
- 241000969468 Athyriaceae Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241001148771 Blechnaceae Species 0.000 description 1
- 241001148764 Blechnopsis orientalis Species 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 241000514038 Brainea insignis Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241001450685 Corallium japonicum Species 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 206010012373 Depressed level of consciousness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241001148765 Dryopteridaceae Species 0.000 description 1
- 241000393483 Dryopteris crassirhizoma Species 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000006404 Lunathyrium Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000196123 Matteuccia Species 0.000 description 1
- 208000034762 Meningococcal Infections Diseases 0.000 description 1
- 206010058858 Meningococcal bacteraemia Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 241000196128 Osmundaceae Species 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229940097572 chloromycetin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000022089 meningococcemia Diseases 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an injection for treating epidemic cerebrospinal meningitis. The injection is mainly prepared from the following raw medicinal materials in parts by weight: 0.5-1.2 parts of cyrtomium fortunei, 0.4-1.2 parts of fructus forsythiae, 0.8-1.6 parts of isatis root, 0.3-0.8 part of galinsoga parviflora, and 0.6-1.5 parts of entireleaf neoalsomitra. The injection is prepared from the pure traditional Chinese medicinal materials, has the efficacies of clearing away heat and toxic materials, as well as diminishing inflammation and relieving pain, and is low in cost, and proved by the clinical test, the injection has definite curative effects for patients suffering from epidemic cerebrospinal meningitis, and is stable in curative effects.
Description
Divisional application, original applying number 2014106539379, applying date 2014.11.18, injection of title treatment epidemic cerebrospinal meningitis and preparation method thereof.
Technical field
The present invention relates to traditional Chinese medicine field, particularly relate to a kind of injection for the treatment of epidemic cerebrospinal meningitis and preparation method thereof.
Background technology
Epidemic cerebrospinal meningitis is called for short epidemic encephalitis, is the purulent meningitis caused by meningococcus.Pathogenic bacterium invade blood circulation by nasopharynx part, form septicemia, are finally confined to meninges and membrane of spinal cord, form suppurative meninges pathological changes.Main clinical manifestation has heating, and the meningeal irritation signs such as headache, vomiting, skin petechia and stiffness of the neck, cerebrospinal fluid is suppurative change.Meningococcus can not be invaded meninges and only show as septicemia, and wherein severe one can the outbreak in fulminant type.Infect and also can betide upper and lower respiratory tract, joint, the position such as pericardium and eye.Primary disease, in distribute or large and small popular, take child morbidity as height.The state of an illness of epidemic encephalitis is complicated and changeable, and weight differs, and generally can show as three Clinical types, i.e. plain edition, fulminant type and chronic septicemia.In addition, still atypical presentation person is had.1 ~ 7 day incubation period, be generally 2 ~ 3 days.1. plain edition accounts for 90% of whole meningococcal infection sequela.By primary disease evolution, upper respiratory tract infection phase, septicemia phase and meningitis phase three phases can be divided into, but be difficult to clinically divide.Sometimes the state of an illness ends at the septicemia phase and occurs without meningitis, and the meningitis phase then has septicemia to exist simultaneously.Even if the medium-sized state of an illness also weight differs.2. fulminant type small number of patients onset is hurried, and patient's condition is dangerous, as rescued not in time, often in 24h, even in 6h, getting final product threat to life, being called fulminant type.3. this kind of is rare for chronic meningococcemia.Comparatively be more common in adult.The course of disease often delays the several months long.Publication number CN102846811A(application number 201110176084.0) Chinese patent literature disclose a kind of prescription for the treatment of epidemic cerebrospinal meningitis, make for raw material with Scolopendra, scorpion tail, Radix Gentianae, Herba Tagetis Patulae, Fructus Forsythiae, Bombyx Batryticatus, Pheretima, double hook, Radix Paeoniae Alba, Radix Glycyrrhizae Preparata, Caulis Polygoni Multiflori, Fructus Tribuli, the Radix Rehmanniae, Radix Panacis Quinquefolii, Moschus, Calculus Bovis, Cornu Saigae Tataricae.Publication number CN103830523A(application number 201410082018.0) Chinese patent literature disclose treatment epidemic cerebrospinal meningitis Chinese medicine composition, raw material consists of Radix Isatidis 10-15g, Radix Scutellariae 3-5g, Cortex Phellodendri 3-5g, Fructus Gardeniae 3-5g, Concha rapanae thomasianae 10-15g, Hirudo 1.5-3g, Corallium Japonicum Kishinouye 9-12g, Radix Glycyrrhizae 5-9g, Rhizoma Anemarrhenae 10-15 gram, Radix Saposhnikoviae 10-15g, Cortex Moutan 10-15 gram, Radix Ginseng Rubra 9-12g, Radix Angelicae Sinensis 9-12g, Rhizoma Atractylodis Macrocephalae 9-12g, Rhizoma Pinelliae 5-9g, Fructus Crataegi 25g, Caulis Akebiae 25g, Rhizoma Cimicifugae 25g, Cinnabaris 3-5g.Notification number CN104042937A(application number 201310079495.7) Chinese patent literature disclose a kind of combination of Chinese medicine for the treatment of epidemic cerebrospinal meningitis, be made up of Chinese medicines such as Gypsum Fibrosum, Radix Gentianae, the Rhizoma Anemarrhenae, Radix Glycyrrhizae, Rhizoma Imperatae, Folium Isatidiss.
Current, many this of doctor trained in Western medicine to this disease adopts antibiotic properties treatment, uses sulphonamides, penicillin and chloromycetin and some other Tri-Biocin, and some medicine that to be patient responsive, use rear side reaction large.If the state of an illness is not tightly endangered, this disease of Chinese traditional treatment has more advantage, and the good traditional Chinese medical science formula of this sick effect of Current therapeutic is also few, and especially the research of Chinese medicine injection does not almost have, and therefore, the TCM investigation about this disease for the treatment of requires further study excavation.
Summary of the invention
For the defect of prior art, the object of this invention is to provide a kind of preparation simply and injection of the treatment epidemic cerebrospinal meningitis of stable curative effect and preparation method thereof.This injection determined curative effect and having no side effect.
Technical scheme of the present invention is:
The injection for the treatment of epidemic cerebrospinal meningitis, is prepared from primarily of following bulk drugs, is weight portion: Rhizoma Osmundae 0.5-1.2, Fructus Forsythiae 0.4-1.5, Radix Isatidis 0.8-1.6, Herba galinsogae parviflorae 0.3-0.8, Neoalsomitra integrifoliola (Cogn.) Hucth. 0.6-1.5.
In preferred scheme, Rhizoma Osmundae 0.7-1.0, Fructus Forsythiae 0.8-1.1, Radix Isatidis 1.0-1.4, Herba galinsogae parviflorae 0.4-0.7, Neoalsomitra integrifoliola (Cogn.) Hucth. 0.8-1.3.
Be more preferably, Rhizoma Osmundae 0.85, Fructus Forsythiae 0.95, Radix Isatidis 1.2, Herba galinsogae parviflorae 0.55, Neoalsomitra integrifoliola (Cogn.) Hucth. 1.05.
The preparation method of the injection of described treatment epidemic cerebrospinal meningitis is:
(1) Fructus Forsythiae and Radix Isatidis decontamination are pulverized, with the soak with ethanol of 80%, percolation, collect percolate, residue is for subsequent use;
(2) infiltrated by Neoalsomitra integrifoliola (Cogn.) Hucth. clear water, section, be then placed in pot and fry to black for spending, sprinkling clear water, cools;
(3) soaked by obtained to Rhizoma Osmundae, Herba galinsogae parviflorae and step (2) medical material, with steam distillation, collect distillate, medicinal residues are for subsequent use;
(4) step (3) remaining medicinal residues are placed in marmite together with step (1) remaining residue, decoct with water three times, filter, merge three filtrates, and be concentrated into 1/2nd of original volume;
(5) by step (1), (4) gained percolate and concentrated solution merge, with alcohol settling process three times, it is 55% that first time makes containing amount of alcohol, second time 65%, third time 75%, after abundant stirring, place 8 hours, filter, filtrate recycling ethanol is extremely without alcohol taste, inject the medicinal carbon with water and 0.5%, stirring is placed in water-bath, heat 1 hour, cool, cold preservation 24h, filter, add step (3) gained distillate, stir evenly, by 5% sodium hydroxide solution adjust ph, finally add the glucose solution of liquor capacity 1%, filter, embedding, boiling sterilization (100 DEG C) 30 minutes, obtain injection.
The injection of described treatment epidemic cerebrospinal meningitis, the amount of step (1) percolation 80% alcoholic solution used is that the 4-7 of medical material weight is doubly (preferred, the amount of percolation 80% alcoholic solution used is 5-6 times of medical material weight, be more preferably, the amount of percolation 80% alcoholic solution used is 5.5 times of medical material weight).
The injection of described treatment epidemic cerebrospinal meningitis, step (3) amount of water is the 4-6 of medical material weight doubly (preferred, amount of water is 5 times of medical material weight).
The injection of described treatment epidemic cerebrospinal meningitis, step (4) decocts three times, each decoction 20-50 minute (preferred, to decoct 30-40 minute at every turn, be more preferably, each decoction 35 minutes).
The injection of described treatment epidemic cerebrospinal meningitis, step (4) amount of water was not for have medical material 2cm to be as the criterion.
The injection of described treatment epidemic cerebrospinal meningitis, step (5) water-bath temperature is 95-100 DEG C (preferred, water-bath temperature is 96-99 DEG C, is more preferably, and water-bath temperature is 98 DEG C).
The injection of described treatment epidemic cerebrospinal meningitis, step (5) adjust ph is preferred to 7.0-7.8(, and adjust ph, to 7.2-7.6, is more preferably, adjust ph to 7.4).
The pharmacology of the present invention's main raw material of Chinese medicine used is as follows:
Rhizoma Osmundae: base is former: be Dryopteridaceae plant dryopteris crassirhizoma, Athyriaceae plant lunathyrium acrostichoidesChing, ball Pteridiaceae plant Matteuccia strthiopteris, Osmundaceae plant osmund, the rhizome of Blechnaceae plant Blechnum orientale Linn., Brainea insignis, Rhizoma Osmundae etc.Nature and flavor: bitter, cool.Gui Jing: enter liver, stomach warp.Function cures mainly: kill ascarid, silk ribbon, pinworm, heat clearing away, removing toxic substances, removing heat from blood, hemostasis.Control anemopyretic cold.Warm macule, spits blood, epistaxis, discharging fresh blood stool, dysentery, metrorrhagia, leukorrhagia, skin infection, hematuria, menorrhagia, and knife injury is hemorrhage, ascarid, rich worm, taeniasis, artificial abortion, postpartum hemorrhage.
Fructus Forsythiae: base is former: be the fruit of Oleaceae plants Fructus Forsythiae.Nature and flavor: bitter, are slightly cold.Gui Jing: return lung, the heart, small intestine meridian.Function cures mainly: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, dispelling wind and heat pathogens.For carbuncle, scrofula, acute mastitis, erysipelas, anemopyretic cold, epidemic febrile disease from the beginning of, warm people battalion, high hot excessive thirst, coma sends out speckle, the puckery pain of pyretic stranguria.
Radix Isatidis: nature and flavor: bitter in the mouth, cold in nature.Gui Jing: GUIXIN warp; Stomach warp.Effect: heat clearing away, removing toxic substances, removing heat from blood, sore-throat relieving.Cure mainly: control influenza, epidemic encephalitis, encephalitis b, pneumonia, erysipelas, pyretic toxicity sends out speckle, and coma tells nosebleed, pharyngeal swelling, mumps, acute catarrhal conjunctivitis, skin ulcer rash, and crimson tongue is purple dark, sore throat, scarlet fever, major part pestilence, carbuncle; Epidemic encephalitis type B, acute, chronic hepatitis, mumps, osteomyelitis can be prevented and treated.
Herba galinsogae parviflorae: base is former: be the herb of feverfew Herba galinsogae parviflorae.Nature and flavor: light are flat.Function cures mainly: hemostasis, antiinflammatory.Cure mainly tonsillitis, pharyngolaryngitis, acute icterohepatitis; Wound hemorrhage is controlled in external.
Neoalsomitra integrifoliola (Cogn.) Hucth.: base is former: the tuber of cucurbitaceous plant Neoalsomitra integrifoliola (Cogn.) Hucth..Nature and flavor: bitter in the mouth; Puckery; Cold in nature.Function cures mainly: heat-clearing and toxic substances removing; Pain relieving.Main bacillary dysentery; Intestinal is scorching; Gastritis; Pharyngolaryngitis; Parotitis; Periodontitis; Epidemic hemorrhagic conjunctivitis; Tonsillitis; High heat; Urinary tract infection.
Not only curative effect is high for the injection for the treatment of epidemic cerebrospinal meningitis provided by the invention, and side effect is little, and in addition, excellent results of the present invention also shows:
1, selected materials is Chinese medicine material, and cost of manufacture is low;
2, this prescription meets Chinese medicine principle, for epidemic cerebrospinal meningitis pathogeny and clinical symptoms, develops;
3, through clinical trial, the present invention proves that popularity cerebrospinal meningitis patient has good curative effect, and stable curative effect.
Detailed description of the invention
Describe technical scheme of the present invention in detail below in conjunction with embodiment and experimental example, but protection domain is not limited thereto.
Embodiment 1 treats the injection of epidemic cerebrospinal meningitis, is prepared from primarily of following bulk drugs: Rhizoma Osmundae 50g, Fructus Forsythiae 40g, Radix Isatidis 80g, Herba galinsogae parviflorae 30g, Neoalsomitra integrifoliola (Cogn.) Hucth. 60g.
The preparation method of the injection of above-mentioned treatment epidemic cerebrospinal meningitis is:
(1) Fructus Forsythiae and Radix Isatidis decontamination are pulverized, with the soak with ethanol of 80% of medical material weight 4 times, percolation, collect percolate, residue is for subsequent use;
(2) infiltrated by Neoalsomitra integrifoliola (Cogn.) Hucth. clear water, section, be then placed in pot and fry to black for spending, sprinkling clear water, cools;
(3) soaked (water weight is 4 times of medical material weight) by obtained to Rhizoma Osmundae, Herba galinsogae parviflorae and step (2) medical material, with steam distillation, collect distillate, medicinal residues are for subsequent use;
(4) step (3) remaining medicinal residues are placed in marmite together with step (1) remaining residue, add water and do not have medical material 2cm, decoct three times, each decoction 20 minutes, filters, merges three filtrates, and be concentrated into 1/2nd of original volume;
(5) by step (1), (4) gained percolate and concentrated solution merge, with alcohol settling process three times, it is 55% that first time makes containing amount of alcohol, second time 65%, third time 75%, after abundant stirring, place 8 hours, filter, filtrate recycling ethanol is extremely without alcohol taste, inject the medicinal carbon with water and 0.5%, stirring is placed in the water-bath of 95 DEG C, heat 1 hour, cool, cold preservation 24h, filter, add step (3) gained distillate, stir evenly, by 5% sodium hydroxide solution adjust ph to 7.0, finally add the glucose solution of liquor capacity 1%, filter, embedding, boiling sterilization (100 DEG C) 30 minutes, obtain injection.
Embodiment 2 treats the injection of epidemic cerebrospinal meningitis, is prepared from primarily of following bulk drugs: Rhizoma Osmundae 12g, Fructus Forsythiae 15g, Radix Isatidis 16g, Herba galinsogae parviflorae 8g, Neoalsomitra integrifoliola (Cogn.) Hucth. 15g.
The preparation method of the injection for the treatment of epidemic cerebrospinal meningitis is:
(1) Fructus Forsythiae and Radix Isatidis decontamination are pulverized, with the soak with ethanol of 80% of medical material weight 7 times, percolation, collect percolate, residue is for subsequent use;
(2) infiltrated by Neoalsomitra integrifoliola (Cogn.) Hucth. clear water, section, be then placed in pot and fry to black for spending, sprinkling clear water, cools;
(3) soaked (water weight is 6 times of medical material weight) by obtained to Rhizoma Osmundae, Herba galinsogae parviflorae and step (2) medical material, with steam distillation, collect distillate, medicinal residues are for subsequent use;
(4) step (3) remaining medicinal residues are placed in marmite together with step (1) remaining residue, add water and do not have medical material 2cm, decoct three times, each decoction 50 minutes, filters, merges three filtrates, and be concentrated into 1/2nd of original volume;
(5) by step (1), (4) gained percolate and concentrated solution merge, with alcohol settling process three times, it is 55% that first time makes containing amount of alcohol, second time 65%, third time 75%, after abundant stirring, place 8 hours, filter, filtrate recycling ethanol is extremely without alcohol taste, inject the medicinal carbon with water and 0.5%, stirring is placed in the water-bath of 100 DEG C, heat 1 hour, cool, cold preservation 24h, filter, add step (3) gained distillate, stir evenly, by 5% sodium hydroxide solution adjust ph to 7.8, finally add the glucose solution of liquor capacity 1%, filter, embedding, boiling sterilization (100 DEG C) 30 minutes, obtain injection.
Model case: xxx, female, 12 years old.Before 4 days, generate heat suddenly in the evening, thinks flu of catching a cold, take febrifuge, body temperature is in a slight decrease, after recover again, the next morning occur headache, nausea and vomiting, household extremely worries, then medical, time medical, lip cyanosis, have more visible ecchymosis with it, wear through waist, hemoculture, rabat etc. inspection is diagnosed as epidemic cerebrospinal encephalitis.
Skin test finds that patient is irritated to cephalo-type antibiolics, carries out penicillin transfusion, DeGrain after 4 days of infusing, symptom has no improvement, so use the injection of the present embodiment gained treatment epidemic cerebrospinal meningitis, every day 1 time, each 10ml, intramuscular injection, 7 days courses for the treatment of.Inject after 2 days, temperature recovery is normal, and headache obviously alleviates, and after 4 days, nausea and vomiting disappears, and appetite becomes good, and after injecting one week, all malaise symptoms of patient all disappear, and continues injection 3 days consolidate curative effect again, and patient fully recovers.
Embodiment 3 treats the injection of epidemic cerebrospinal meningitis, is prepared from primarily of following bulk drugs: Rhizoma Osmundae 70g, Fructus Forsythiae 80g, Radix Isatidis 100g, Herba galinsogae parviflorae 40g, Neoalsomitra integrifoliola (Cogn.) Hucth. 80g.
The preparation method of the injection for the treatment of epidemic cerebrospinal meningitis is:
(1) Fructus Forsythiae and Radix Isatidis decontamination are pulverized, with the soak with ethanol of 80% of medical material weight 5 times, percolation, collect percolate, residue is for subsequent use;
(2) infiltrated by Neoalsomitra integrifoliola (Cogn.) Hucth. clear water, section, be then placed in pot and fry to black for spending, sprinkling clear water, cools;
(3) soaked (water weight is 4 times of medical material weight) by obtained to Rhizoma Osmundae, Herba galinsogae parviflorae and step (2) medical material, with steam distillation, collect distillate, medicinal residues are for subsequent use;
(4) step (3) remaining medicinal residues are placed in marmite together with step (1) remaining residue, add water and do not have medical material 2cm, decoct three times, each decoction 30 minutes, filters, merges three filtrates, and be concentrated into 1/2nd of original volume;
(5) by step (1), (4) gained percolate and concentrated solution merge, with alcohol settling process three times, it is 55% that first time makes containing amount of alcohol, second time 65%, third time 75%, after abundant stirring, place 8 hours, filter, filtrate recycling ethanol is extremely without alcohol taste, inject the medicinal carbon with water and 0.5%, stirring is placed in the water-bath of 96 DEG C, heat 1 hour, cool, cold preservation 24h, filter, add step (3) gained distillate, stir evenly, by 5% sodium hydroxide solution adjust ph to 7.2, finally add the glucose solution of liquor capacity 1%, filter, embedding, boiling sterilization (100 DEG C) 30 minutes, obtain injection.
Model case: xxx, man, 61 years old.During morning exercises, prominent sense is uncomfortable, dizzy weak, and neighbours are sent back home rests, soon occur again vomitting, because it suffers from hypertension, dare not arbitrarily medication, and just control so be sent to hospital emergency.Time medical, obnubilation, restlessness, spirit is not good enough, dizzy, and vomiting, skin has speckle not of uniform size, through multiple inspection, be finally diagnosed as epidemic cerebrospinal meningitis.
The injection of injection the present embodiment gained treatment epidemic cerebrospinal meningitis, adopts once a day, each 10ml, intramuscular injection, 7 days courses for the treatment of.Inject after 3 days, dizzy, symptoms of emesis disappears, and spirit is improved, and appetite becomes good, continues injection after one week, and ecchymosis disappears and loses with it, and patient mental is good, and each side reaction is good, and patient fully recovers, and has no recurrence in later six months.
Embodiment 4 treats the injection of epidemic cerebrospinal meningitis, is prepared from primarily of following bulk drugs: Rhizoma Osmundae 10g, Fructus Forsythiae 11g, Radix Isatidis 14g, Herba galinsogae parviflorae 7g, Neoalsomitra integrifoliola (Cogn.) Hucth. 13g.
The preparation method of the injection for the treatment of epidemic cerebrospinal meningitis is:
(1) Fructus Forsythiae and Radix Isatidis decontamination are pulverized, with the soak with ethanol of 80% of medical material weight 6 times, percolation, collect percolate, residue is for subsequent use;
(2) infiltrated by Neoalsomitra integrifoliola (Cogn.) Hucth. clear water, section, be then placed in pot and fry to black for spending, sprinkling clear water, cools;
(3) soaked (water weight is 6 times of medical material weight) by obtained to Rhizoma Osmundae, Herba galinsogae parviflorae and step (2) medical material, with steam distillation, collect distillate, medicinal residues are for subsequent use;
(4) step (3) remaining medicinal residues are placed in marmite together with step (1) remaining residue, add water and do not have medical material 2cm, decoct three times, each decoction 40 minutes, filters, merges three filtrates, and be concentrated into 1/2nd of original volume;
(5) by step (1), (4) gained percolate and concentrated solution merge, with alcohol settling process three times, it is 55% that first time makes containing amount of alcohol, second time 65%, third time 75%, after abundant stirring, place 8 hours, filter, filtrate recycling ethanol is extremely without alcohol taste, inject the medicinal carbon with water and 0.5%, stirring is placed in the water-bath of 99 DEG C, heat 1 hour, cool, cold preservation 24h, filter, add step (3) gained distillate, stir evenly, by 5% sodium hydroxide solution adjust ph to 7.6, finally add the glucose solution of liquor capacity 1%, filter, embedding, boiling sterilization (100 DEG C) 30 minutes, obtain injection.
Embodiment 5 treats the injection of epidemic cerebrospinal meningitis, is prepared from primarily of following bulk drugs: Rhizoma Osmundae 85g, Fructus Forsythiae 95g, Radix Isatidis 120g, Herba galinsogae parviflorae 55g, Neoalsomitra integrifoliola (Cogn.) Hucth. 105g.
The preparation method of the injection for the treatment of epidemic cerebrospinal meningitis is:
(1) Fructus Forsythiae and Radix Isatidis decontamination are pulverized, with the soak with ethanol of 80% of medical material weight 5.5 times, percolation, collect percolate, residue is for subsequent use;
(2) infiltrated by Neoalsomitra integrifoliola (Cogn.) Hucth. clear water, section, be then placed in pot and fry to black for spending, sprinkling clear water, cools;
(3) soaked (water weight is 5 times of medical material weight) by obtained to Rhizoma Osmundae, Herba galinsogae parviflorae and step (2) medical material, with steam distillation, collect distillate, medicinal residues are for subsequent use;
(4) step (3) remaining medicinal residues are placed in marmite together with step (1) remaining residue, add water and do not have medical material 2cm, decoct three times, each decoction 35 minutes, filters, merges three filtrates, and be concentrated into 1/2nd of original volume;
(5) by step (1), (4) gained percolate and concentrated solution merge, with alcohol settling process three times, it is 55% that first time makes containing amount of alcohol, second time 65%, third time 75%, after abundant stirring, place 8 hours, filter, filtrate recycling ethanol is extremely without alcohol taste, inject the medicinal carbon with water and 0.5%, stirring is placed in the water-bath of 98 DEG C, heat 1 hour, cool, cold preservation 24h, filter, add step (3) gained distillate, stir evenly, by 5% sodium hydroxide solution adjust ph to 7.4, finally add the glucose solution of liquor capacity 1%, filter, embedding, boiling sterilization (100 DEG C) 30 minutes, obtain injection.
The clinical practice of injection of test example 1 embodiment 5 gained treatment epidemic cerebrospinal meningitis: in JIUYUE, 2011 in June ,-2013,248 routine common epidemic cerebrospinal meningitis out-patients are screened in 6 hospitals, wherein women 118 example, male 130 example, oldest 18 years old, minimal ages 1 years old, 9.5 years old mean age.Diagnostic criteria:: (1), how in spring and summer and morbidity early autumn, often has virus infection history.(2) heating is had, headache, vomiting, diarrhoea, disturbance of consciousness, even the symptoms such as stupor of fainting from fear.Infant bregma is full.(3) meningeal irritation sign is positive, sometimes can draw pathologic reflex.(4) cerebrospinal fluid outward appearance is limpid or micro-muddy, and pressure slightly increases, and cell number is mostly between 10 ~ 500/mm3, and lymphocyte occupies the majority.Albumen slightly increases, sugar and chloride normal.Minority case cerebrospinal fluid is without obvious change.The person of having ready conditions can make virus purification and Serological testing.(5) electroencephalogram: often occur diffused inactive echoes.
Patient is divided into two groups at random, experimental group 168 example and matched group 80 routine, two groups in sex, age, the course of disease, the state of an illness etc. without significant difference (P > 0.05), there is comparability.Experimental group takes embodiment 5 products obtained therefrom, and once, intramuscular injection, each 10m1(adjusts to some extent depending on concrete condition in injection every day), 7 days courses for the treatment of, matched group injects other medicine conventional medication such as () sulfadiazine, benzylpenicillin, ampicillin.Period in a medicine carries out Continuous Observation to two groups of patients, record symptom and change.
Curative effect situation criterion: cure: clinical symptoms all disappears, physical and chemical index inspection is normal, observes and within three months, has no repeatedly; Effective: clinical symptom relief, the state of an illness is controlled, physical and chemical index inspection improvement or normal; Invalid: clinical symptoms is without being clearly better or increasing the weight of.Result is as shown in table 1.
Table 1 liang group patient treatment outcome
As shown in Table 1: during treatment, the experimental group patient of the injection of injection embodiment 5 gained treatment epidemic cerebrospinal meningitis, cures and effective number of cases is respectively 105 and 55, and the total effective rate of experimental group is 95.2%.The total effective rate of matched group is 90%, experimental group is suitable with treatment of control group effect, and experimental group is a shade better, and untoward reaction does not appear in treatments period experimental group patient, matched group has patient to occur untoward reaction to medicament, and the comparatively conventional Western medicine of visible experimental group injection is safer.
Rhizoma Osmundae selected in the present invention's injection, Fructus Forsythiae have the effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, dispelling wind and heat pathogens, also have Radix Isatidis, Herba galinsogae parviflorae, Neoalsomitra integrifoliola (Cogn.) Hucth., removing heat from blood, antiinflammatory, pain relieving, several medicine synergism popularity cerebrospinal meningitis shows good therapeutic effect, pure natural medical material is made, ensure safety, side effect is almost nil.
It should be pointed out that detailed description of the invention is the more representational example of the present invention, obvious technical scheme of the present invention is not limited to above-described embodiment, can also have a lot of distortion.Those of ordinary skill in the art, with the present invention clear and definite disclosed or according to undoubted the obtaining of the written description of file, the claimed scope of this patent all should be thought.
Claims (8)
1. treat the injection of epidemic cerebrospinal meningitis, it is characterized in that, be prepared from primarily of following bulk drugs, be weight portion: Rhizoma Osmundae 0.5, Fructus Forsythiae 0.4, Radix Isatidis 0.8, Herba galinsogae parviflorae 0.3, Neoalsomitra integrifoliola (Cogn.) Hucth. 0.6.
2. the preparation method of the injection for the treatment of epidemic cerebrospinal meningitis as claimed in claim 1, is characterized in that,
(1) Fructus Forsythiae and Radix Isatidis decontamination are pulverized, with the soak with ethanol of 80%, percolation, collect percolate, residue is for subsequent use;
(2) infiltrated by Neoalsomitra integrifoliola (Cogn.) Hucth. clear water, section, be then placed in pot and fry to black for spending, sprinkling clear water, cools;
(3) soaked by obtained to Rhizoma Osmundae, Herba galinsogae parviflorae and step (2) medical material, with steam distillation, collect distillate, medicinal residues are for subsequent use;
(4) step (3) remaining medicinal residues are placed in marmite together with step (1) remaining residue, decoct with water three times, filter, merge three filtrates, and be concentrated into 1/2nd of original volume;
(5) by step (1), (4) gained percolate and concentrated solution merge, with alcohol settling process three times, it is 55% that first time makes containing amount of alcohol, second time 65%, third time 75%, after abundant stirring, place 8 hours, filter, filtrate recycling ethanol is extremely without alcohol taste, inject the medicinal carbon with water and 0.5%, stirring is placed in water-bath, heat 1 hour, cool, cold preservation 24h, filter, add step (3) gained distillate, stir evenly, by 5% sodium hydroxide solution adjust ph, finally add the glucose solution of liquor capacity 1%, filter, embedding, boiling sterilization (100 DEG C) 30 minutes, obtain injection.
3. preparation method as claimed in claim 2, it is characterized in that, the amount of step (1) percolation 80% alcoholic solution used is that the 4-7 of medical material weight is doubly (preferred, the amount of percolation 80% alcoholic solution used is 5-6 times of medical material weight, be more preferably, the amount of percolation 80% alcoholic solution used is 5.5 times of medical material weight).
4. preparation method as claimed in claim 2, is characterized in that, step (3) amount of water is the 4-6 of medical material weight doubly (preferred, amount of water is 5 times of medical material weight).
5. preparation method as claimed in claim 2, is characterized in that, step (4) decoction three times, each decoction 20-50 minute (preferred, each decoction 30-40 minute, is more preferably, each decoction 35 minutes).
6. preparation method as claimed in claim 2, is characterized in that, step (4) amount of water was not for have medical material 2cm to be as the criterion.
7. preparation method as claimed in claim 2, is characterized in that, step (5) water-bath temperature is 95-100 DEG C (preferred, water-bath temperature is 96-99 DEG C, is more preferably, and water-bath temperature is 98 DEG C).
8. preparation method as claimed in claim 2, is characterized in that, step (5) adjust ph is preferred to 7.0-7.8(, and adjust ph, to 7.2-7.6, is more preferably, adjust ph to 7.4).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410653937.9A CN104306457A (en) | 2014-11-18 | 2014-11-18 | Injection liquid for treating epidemic cerebrospinal meningitis and preparation method thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410653937.9A Division CN104306457A (en) | 2014-11-18 | 2014-11-18 | Injection liquid for treating epidemic cerebrospinal meningitis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105521026A true CN105521026A (en) | 2016-04-27 |
Family
ID=52361866
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410653937.9A Pending CN104306457A (en) | 2014-11-18 | 2014-11-18 | Injection liquid for treating epidemic cerebrospinal meningitis and preparation method thereof |
| CN201610068054.0A Withdrawn CN105616516A (en) | 2014-11-18 | 2014-11-18 | Epidemic cerebrospinal meningitis treating injection and preparation method thereof |
| CN201610068051.7A Withdrawn CN105616515A (en) | 2014-11-18 | 2014-11-18 | Injection for epidemic cerebrospinal meningitis |
| CN201610068053.6A Withdrawn CN105521026A (en) | 2014-11-18 | 2014-11-18 | Injection for treating epidemic cerebrospinal meningitis |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410653937.9A Pending CN104306457A (en) | 2014-11-18 | 2014-11-18 | Injection liquid for treating epidemic cerebrospinal meningitis and preparation method thereof |
| CN201610068054.0A Withdrawn CN105616516A (en) | 2014-11-18 | 2014-11-18 | Epidemic cerebrospinal meningitis treating injection and preparation method thereof |
| CN201610068051.7A Withdrawn CN105616515A (en) | 2014-11-18 | 2014-11-18 | Injection for epidemic cerebrospinal meningitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (4) | CN104306457A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106309877A (en) * | 2016-09-30 | 2017-01-11 | 毛华养 | Drug for preventing and treating porcine hemagglutinating encephalomyelitis viruses |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103830523A (en) * | 2014-03-07 | 2014-06-04 | 王玉芳 | Traditional Chinese medicine composition for treating epidemic cerebrospinal meningitis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637574A (en) * | 2008-07-30 | 2010-02-03 | 张在文 | Chinese medicinal composition for treating cold |
| CN103479902A (en) * | 2013-07-22 | 2014-01-01 | 郝振荣 | Proved prescription used for treating epidemic cerebrospinal meningitis |
-
2014
- 2014-11-18 CN CN201410653937.9A patent/CN104306457A/en active Pending
- 2014-11-18 CN CN201610068054.0A patent/CN105616516A/en not_active Withdrawn
- 2014-11-18 CN CN201610068051.7A patent/CN105616515A/en not_active Withdrawn
- 2014-11-18 CN CN201610068053.6A patent/CN105521026A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103830523A (en) * | 2014-03-07 | 2014-06-04 | 王玉芳 | Traditional Chinese medicine composition for treating epidemic cerebrospinal meningitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104306457A (en) | 2015-01-28 |
| CN105616515A (en) | 2016-06-01 |
| CN105616516A (en) | 2016-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101439164B (en) | Method for preparing Chinese medicine for treating sthenia fire type aphtha | |
| CN104189789A (en) | Traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis | |
| CN104524287A (en) | Traditional Chinese medicinal composition for treating anaphylactoid purpura and preparation method of traditional Chinese medicinal composition | |
| CN104306679A (en) | Chinese herb agentia for treating epidemic cerebrospinal meningitis and preparation method thereof | |
| CN103830523A (en) | Traditional Chinese medicine composition for treating epidemic cerebrospinal meningitis | |
| CN104587219A (en) | Traditional Chinese medicine for treating functional uterine bleeding | |
| CN104644967A (en) | Pharmaceutical composition for treating I-type diabetes and application thereof | |
| CN107929670A (en) | A kind of Medicated eye-mask for treating eye-blurred and preparation method thereof | |
| CN105521026A (en) | Injection for treating epidemic cerebrospinal meningitis | |
| CN106138785A (en) | One treats neurasthenic Chinese medicine composition and preparation method thereof | |
| CN104721624A (en) | Internal medicament for treating adenovirus pneumonia and preparation method of internal medicament | |
| CN101181430A (en) | Chinese medicine medicament for curing rosalia lupus | |
| CN103055115A (en) | Chinese patent medicine for treating infantile eczema | |
| CN101095919A (en) | Chinese patent drug for treating diabetes gallstone | |
| CN104352571B (en) | The injection for the treatment of epidemic encephalitis and preparation method | |
| CN102228661B (en) | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis | |
| CN101085255A (en) | Traditional Chinese medicine preparation for treating acute nephritis | |
| CN101085312A (en) | Traditional Chinese medicine for treating hyperdyroidism | |
| CN105708906A (en) | Injection for treating epidemic cerebrospinal meningitis | |
| CN108721534A (en) | A kind of Chinese medicine preparation for treating aphthae | |
| CN106620140A (en) | Traditional Chinese medicine composition for treating foot rot of buffaloes | |
| CN106491954A (en) | A kind of treat Chinese medicine composition of lung abscess and preparation method thereof | |
| CN105663657A (en) | Decoction medicine capable of effectively treating fire excess from yin deficiency and preparation method thereof | |
| CN105535322A (en) | Orally-taken medicine capable of effectively treating exogenous disease and preparation method thereof | |
| CN104784567B (en) | A kind of pharmaceutical composition for the treatment of urinary system infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: Beijing District of Gansu province Ludongming 730900 Baiyin District No. 4 1-502 Applicant after: Hao Jianyou Address before: Huaiyin District of Ji'nan City, Shandong province 250000 Ji Qi Road No. 112 Applicant before: Hao Jianyou |
|
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160427 |